Pfreundschuh Pfreundschuh M M Schubert Schubert J J Ziepert Ziepert M M Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol Lancet Oncol 2008 2008 9 9 105 105 116 116 10.1016/S1470-2045(08)70002-0 10.1016/S1470-2045(08)70002-0 supplied-pmid 18226581? Here, DDIT3 is linked to B-cell non-Hodgkin lymphoma.